Clinical trials with etanidazole (SR-2508) by the Radiation Therapy Oncology Group (RTOG).

[1]  C. Coleman,et al.  Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study. , 1989, International journal of radiation oncology, biology, physics.

[2]  J. Overgaard,et al.  Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study. , 1989, International journal of radiation oncology, biology, physics.

[3]  T. Pajak,et al.  A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04). , 1989, International journal of radiation oncology, biology, physics.

[4]  T. Phillips,et al.  A progress report of the rtog head and neck SR-2508 trial , 1989 .

[5]  T. Pajak,et al.  Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck. , 1987, International journal of radiation oncology, biology, physics.

[6]  C. Coleman,et al.  Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile. , 1987, Cancer research.

[7]  C. Coleman,et al.  Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. , 1986, International journal of radiation oncology, biology, physics.

[8]  C. Coleman,et al.  Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508. , 1984, International journal of radiation oncology, biology, physics.

[9]  T. Phillips,et al.  Clinical trials of hypoxic cell sensitizers. , 1982, International journal of radiation oncology, biology, physics.

[10]  R. Goodman,et al.  The value of adjuvant misonidazole in the definitive irradiation of advanced head and neck squamous cancer: an RTOG pilot study (#78-02). , 1979, International journal of radiation oncology, biology, physics.

[11]  J. Henk,et al.  RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER Interim Report of Second Clinical Trial , 1977, The Lancet.

[12]  J. Henk,et al.  RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCER Final Report of First Controlled Clinical Trial , 1977, The Lancet.

[13]  Rowlands Df.  Letter: Poliomyelitis today. , 1976 .

[14]  S. Inceman,et al.  HEPARIN AND EMBOLISM , 1976, The Lancet.